Drug companies are quietly pushing through price hikes of 100% — or even more than 1,000% — for a very small but growing number of prescription drugs, helping to drive up costs for insurers, patients and government programs.
Among the examples: Questcor Pharmaceuticals last August raised the wholesale price on Acthar, which treats spasms in babies, from about $1,650 a vial to more than $23,000. Ovation raised the cost of Cosmegen, which treats a type of tumor, from $16.79 to $593.75 in January 2006.
The average wholesale price of 26 brand-name drugs jumped 100% or more in a single cost adjustment last year, up from 15 in 2004, the university study found. In the first half of this year, 17 drugs made the list.
A Michigan judge has refused to allow 10 defendants charged with violating the medical marijuana law...
Smoking marijuana modestly reduced pain and other symptoms of chronic neuropathic pain, results of a small...
Allergan Inc., the maker of wrinkle-smoothing Botox, says it will pay $600 million to settle a...
Even as supporters of human embryonic stem cell research are reeling from last week's sudden cutoff...
